Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

High-yield and Functional IgY Anti-S1 SARS-CoV-2 Delta Variant from Chicken Immunized with In-house Recombinant Protein

The Indonesian Biomedical Journal · Vol. 17 No. 4 (2025) · hlm. 363–372

DOI
10.18585/inabj.v17i4.3693
ISSN
2085-3297, 2355-9179
Terbit
2025-08-25
Penerbit
Secretariat of The Indonesian Biomedical Journal
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc/4.0/

Abstrak

BACKGROUND: During COVID-19 pandemic, effective preventive and therapeutic strategies was urgently necessary, especially with the emerging Delta variants. Previous existing interventions have some limitations, and passive immunization using immunoglobulin Y (IgY) is considered viable. However, the potential of IgY antibodies remains underexplored locally. Therefore, a feasible study was conducted to produce IgY against the SARS-CoV-2 Delta variant from chickens raised on a farm, instead of a laboratory environment, by using in-house recombinant protein, to offer a promising low-cost alternative for passive immunization.METHODS: In-house HEK293 cell line was produced by secreting recombinant S1 subunit protein of SARS-CoV-2 Delta variant. The protein was confirmed by western blot and used as an immunogen in two chickens. IgY was extracted from egg yolks. Titers and neutralization activity of IgY against SARS-CoV-2 Delta variant were confirmed by enzyme-linked immunosorbent assay (ELISA) and surrogate virus neutralization test (sVNT). The functionality of IgY was then tested on lysates from COVID-19 patients' nasopharyngeal swabs with dot blot method.RESULTS: The high anti-S1 IgY titers and neutralization activity was confirmed following immunization with 1 mg immunogen at 2–3-week intervals. IgY titers varied between chickens and time points. The mean titers showed significant increase after the fifth immunization (1.21, 1.72 and 1.48; with p<0.05 for all). Neutralization activity appeared after the second immunization and was significant after the third immunization (31.9%, 34.95%, 26.9%, 47.6%, 54.95% and 57.3%; with p<0.05 for all). The results of this study showed that the extracted IgY reacted to COVID-19 patients' nasopharyngeal swabs lysates.CONCLUSION: A high-yield and functional IgY anti-S1 SARS-CoV-2 Delta variant can be produced from chicken immunized with an in-house recombinant protein. This can be an alternative for affordable and effective IgY production during public health emergencies.KEYWORDS: IgY, SARS-CoV-2, S1 subunit protein, egg yolk, chicken

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 157 tautan kepenulisan bersama · 53 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Airlangga
  • Mochtar Riady Institute for Nanotechnology
  • Hasanuddin University
  • IPB University
  • Pelita Harapan University
  • University of Indonesia
  • Universitas Trisakti
  • Organisasi lain
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Andi WijayaHasanuddin University3
Ferry SandraUniversitas Trisakti3
Sri Pantja MadyawatiUniversitas Airlangga2
Andi Asadul IslamHasanuddin University2
Eka Julianta WahjoepramonoPelita Harapan University2
Mirni LamidUniversitas Airlangga1
Tarzan PurnomoUniversitas Airlangga1
Sarmanu SarmanuUniversitas Airlangga1
Sri HidanahUniversitas Airlangga1
Widya Paramita LokapirnasariUniversitas Airlangga1
Imam MustofaUniversitas Airlangga1
Rini FajarwatiAfiliasi tidak diketahui1
Mohammad SukmanadiUniversitas Airlangga1
Pudji SriantoUniversitas Airlangga1
Trilas SardjitoUniversitas Airlangga1
Muhammad Aftabuddin RzAfiliasi tidak diketahui1
Ismudiono IsmudionoUniversitas Airlangga1
Yoes Prijatna DachlanUniversitas Airlangga1
Loeki Enggar FitriUniversity of Brawijaya1
Lilik MaslachahUniversitas Airlangga1
Bachtiar MurtalaHasanuddin University1
Terawan Agus PutrantoGatot Soebroto Army Hospital1
Silmi MariyaIPB University1
Harsan HarsanPelita Harapan University1
Meily L KurniawidjajaUniversity of Indonesia1
Nuri Purwito AdiUniversity of Indonesia1
Mulyana MulyanaHasanuddin University1
Benyamin LukitoPelita Harapan University1
Ivet Marita SuriapranataMochtar Riady Institute for Nanotechnology1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764892910, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">High-yield and Functional IgY Anti-S1 SARS-CoV-2 Delta Variant from Chicken Immunized with In-house Recombinant Protein</dc:title><dc:creator>Kamaluddin Zarkasie</dc:creator><dc:creator>Teridah Ernala Ginting</dc:creator><dc:creator>Andrea Hynan Poeloengan</dc:creator><dc:creator>Febi Andriani</dc:creator><dc:creator>Aksar Chair Lages</dc:creator><dc:creator>Vina Cornelia</dc:creator><dc:creator>Anggah Nugraha</dc:creator><dc:creator>Bustanur Rosidi</dc:creator><dc:creator>Setyarina Indrasari</dc:creator><dc:creator>Chairul Anwar Nidom</dc:creator><dc:creator>Irawan Yusuf</dc:creator><dc:subject>IgY</dc:subject><dc:subject>Delta variant</dc:subject><dc:subject>spike protein S1</dc:subject><dc:subject>passive immunization</dc:subject><dc:subject>chicken immunization</dc:subject><dc:subject>egg yolk antibodies</dc:subject><dc:subject>neutralizing antibodies</dc:subject><dc:subject>COVID-19 prevention</dc:subject><dc:description xml:lang="en">BACKGROUND: During COVID-19 pandemic, effective preventive and therapeutic strategies was urgently necessary, especially with the emerging Delta variants. Previous existing interventions have some limitations, and passive immunization using immunoglobulin Y (IgY) is considered viable. However, the potential of IgY antibodies remains underexplored locally. Therefore, a feasible study was conducted to produce IgY against the SARS-CoV-2 Delta variant from chickens raised on a farm, instead of a laboratory environment, by using in-house recombinant protein, to offer a promising low-cost alternative for passive immunization.METHODS: In-house HEK293 cell line was produced by secreting recombinant S1 subunit protein of SARS-CoV-2 Delta variant. The protein was confirmed by western blot and used as an immunogen in two chickens. IgY was extracted from egg yolks. Titers and neutralization activity of IgY against SARS-CoV-2 Delta variant were confirmed by enzyme-linked immunosorbent assay (ELISA) and surrogate virus neutralization test (sVNT). The functionality of IgY was then tested on lysates from COVID-19 patients' nasopharyngeal swabs with dot blot method.RESULTS: The high anti-S1 IgY titers and neutralization activity was confirmed following immunization with 1 mg immunogen at 2–3-week intervals. IgY titers varied between chickens and time points. The mean titers showed significant increase after the fifth immunization (1.21, 1.72 and 1.48; with p&lt;0.05 for all). Neutralization activity appeared after the second immunization and was significant after the third immunization (31.9%, 34.95%, 26.9%, 47.6%, 54.95% and 57.3%; with p&lt;0.05 for all). The results of this study showed that the extracted IgY reacted to COVID-19 patients' nasopharyngeal swabs lysates.CONCLUSION: A high-yield and functional IgY anti-S1 SARS-CoV-2 Delta variant can be produced from chicken immunized with an in-house recombinant protein. This can be an alternative for affordable and effective IgY production during public health emergencies.KEYWORDS: IgY, SARS-CoV-2, S1 subunit protein, egg yolk, chicken</dc:description><dc:publisher>Secretariat of The Indonesian Biomedical Journal</dc:publisher><dc:date>2025-08-25</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.18585/inabj.v17i4.3693</dc:identifier><dc:identifier>10.18585/inabj.v17i4.3693</dc:identifier><dc:source>The Indonesian Biomedical Journal; Vol 17 No 4 (2025); 363-372</dc:source><dc:source>2085-3297</dc:source><dc:source>2355-9179</dc:source><dc:language>en</dc:language><dc:relation>https://inabj.org/index.php/ibj/article/download/3693/787</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>